O uso do licopeno no tratamento da Leucoplasia Bucal

dc.contributorEvandro Neves Abdo
dc.contributorOzair Leite
dc.contributorVladimir Reimar Augusto de Souza Noronha
dc.creatorMaria Beatriz Pires de Magalhaes
dc.date.accessioned2019-08-12T16:32:29Z
dc.date.accessioned2022-10-03T22:49:48Z
dc.date.available2019-08-12T16:32:29Z
dc.date.available2022-10-03T22:49:48Z
dc.date.created2019-08-12T16:32:29Z
dc.date.issued2011-12-16
dc.identifierhttp://hdl.handle.net/1843/BUOS-9E9J3A
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3811494
dc.description.abstractConsidering that leukoplakia is the premalignant lesion which suffers the most malignant transformation, the study aims to better understand their behavior in the malignant transformation and oral cancer(CA) itself, since these premalignant lesions are present in up to 60% with the oral CA. The development of chemotherapy provides an opportunity to control the CA by noninvasive methods. The use of lycopene inhibits human oral cancer cells, inducing apoptosis. A case report of a patient diagnosed with clinical and histopathological oral leukoplakia initially measuring 4.5 cm treated with the use of lycopene from tomatoes at the Service of Stomatology, School of Dentistry, Federal University of Minas Gerais (FOUFMG) is presented.
dc.publisherUniversidade Federal de Minas Gerais
dc.publisherUFMG
dc.rightsAcesso Aberto
dc.subjectLeucoplasia bucal
dc.subjectLicopeno
dc.subjectPré-maligno
dc.titleO uso do licopeno no tratamento da Leucoplasia Bucal
dc.typeMonografias de Especialização


Este ítem pertenece a la siguiente institución